Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study.

MLA

Santiago, T., et al. “Patients’ and Rheumatologists’ Perspectives on the Efficacy and Safety of Low-Dose Glucocorticoids in Rheumatoid Arthritis-an International Survey within the GLORIA Study.” Rheumatology (Oxford, England), vol. 60, no. 7, July 2021, pp. 3334–42. EBSCOhost, https://doi.org/10.1093/rheumatology/keaa785.

APA

Santiago, T., Voshaar, M., de Wit, M., Carvalho, P. D., Buttgereit, F., Cutolo, M., Paolino, S., Castelar Pinheiro, G. R., Boers, M., & Da Silva, J. A. P. (2021). Patients’ and rheumatologists’ perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study. Rheumatology (Oxford, England), 60(7), 3334–3342. https://doi.org/10.1093/rheumatology/keaa785

Chicago

Santiago, T, M Voshaar, M de Wit, P D Carvalho, F Buttgereit, M Cutolo, S Paolino, G R Castelar Pinheiro, M Boers, and J A P Da Silva. 2021. “Patients’ and Rheumatologists’ Perspectives on the Efficacy and Safety of Low-Dose Glucocorticoids in Rheumatoid Arthritis-an International Survey within the GLORIA Study.” Rheumatology (Oxford, England) 60 (7): 3334–42. doi:10.1093/rheumatology/keaa785.